Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Das Anti-doping-Gesetz / / herausgegeben von Prof. Dr. Bernhard Pfister ; mit Beiträgen von Afred Bindels, Martin Heger und Bernhard Pfister
| Das Anti-doping-Gesetz / / herausgegeben von Prof. Dr. Bernhard Pfister ; mit Beiträgen von Afred Bindels, Martin Heger und Bernhard Pfister |
| Pubbl/distr/stampa | Stuttgart, [Germany] : , : iBoorberg, , 2016 |
| Descrizione fisica | 1 online resource (71 pages) |
| Disciplina | 344.04233 |
| Collana | Recht und Sport |
| Soggetto topico | Drugs - Law and legislation |
| ISBN | 3-415-05891-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Record Nr. | UNINA-9910162997003321 |
| Stuttgart, [Germany] : , : iBoorberg, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antitrust in Pharmaceutical Markets & Geographical Rules of Origin / / edited by Pierre Kobel, Pranvera Këllezi, Bruce Kilpatrick
| Antitrust in Pharmaceutical Markets & Geographical Rules of Origin / / edited by Pierre Kobel, Pranvera Këllezi, Bruce Kilpatrick |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XV, 497 p. 4 illus., 3 illus. in color.) |
| Disciplina | 344.04233 |
| Collana | LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition |
| Soggetto topico |
Information technology - Law and legislation
Mass media - Law and legislation Pharmacology International law Trade regulation Conflict of laws Comparative law Medical laws and legislation Commercial law IT Law, Media Law, Intellectual Property International Economic Law, Trade Law Private International Law, International and Foreign Law, Comparative Law Medical Law Business Law |
| ISBN | 3-319-55813-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Antitrust in Pharmaceutical Markets: International Report by Stephen Dnes -- Australia by Julie Clarke and Barbora Jedličková -- Austria by Gerhard Fussenegger and Rainer Schultes -- Belgium by Koen T’Syen -- Czech Republic by Kamil Nejezchleb -- France by Liliana Eskenazi, Olivier Freget, Laetitia Ghebali, Clément Hubert, Martina Isola, Nizar Lajnef and Jean-Julien Lemonnier -- Hungary by Gusztav Bacher and András Horváth -- India by Arunabha Ganguli -- Italy by Elisa Teti and Ottavia Raffaelli -- Malta by Clement Mifsud-Bonnici -- Poland by Aleksander Stawicki, Paulina Komorowska and Juliusz Krzyżanowski -- Sweden by Vladimir Bastidas Venegas -- Switzerland by Dominique Guex -- The Netherlands by Cees Jan de Boer and Maria Geilmann -- Ukraine by Viktoriia Gladka and Mariia Baranovych -- United Kingdom by James Bourke -- Part II: Geographical Rules of Origin: International Report by Simon Holzer -- Austria by Christoph Petsch and Michael Meyenburg -- Belgium by Claire Hazée -- Brazil by Felipe Barros Oquendo -- France by Guillaume Couet and Martina Isola -- Germany by Olaf Sosnitza -- Hungary by Ádám Liber -- Japan by Noriko Itai, Kenta Sugimoto and Shigeshi Tanaka -- Malta by Philip Mifsud and Elise Dingli -- Poland by Aleksandra Wędrychowska-Karpińska and Agnieszka Wiercińska-Krużewska. |
| Record Nr. | UNINA-9910255277303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Complex criminality / / D. Abels, D. Bruin & H. van der Wilt (eds.)
| Complex criminality / / D. Abels, D. Bruin & H. van der Wilt (eds.) |
| Pubbl/distr/stampa | Hague, Netherlands : , : Eleven International Publishing, , 2016 |
| Descrizione fisica | 1 online resource (123 pages) |
| Disciplina | 344.04233 |
| Soggetto topico |
Drugs - Law and legislation
Criminal law |
| ISBN | 94-6274-622-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Complex criminality : an introduction / Denis Abels -- The Dutch law on drugs / Deborah Bruin. -- Experts and the ultimate issue rule / Rolf Hoving -- Maintain proportionate sentencing in rewarding criminal cooperators / Wei Pei -- Expert evidence in criminal legal proceedings : three approaches to ensuring the accuracy of expert evidence in criminal proceedings / Mark Visser -- Dealing with dictators : the importance of interdisciplinary research when addressing complex criminality / Maarthe Weerdesteijn. |
| Record Nr. | UNINA-9910156311103321 |
| Hague, Netherlands : , : Eleven International Publishing, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs, technologies and cyber markets / / guest editors, Karenza Moore and Angus Bancroft
| Drugs, technologies and cyber markets / / guest editors, Karenza Moore and Angus Bancroft |
| Autore | Sultan Aysel |
| Pubbl/distr/stampa | [Place of publication not identified] : , : Emerald Publishing, , [2021] |
| Descrizione fisica | 1 online resource (77 pages) |
| Disciplina | 344.04233 |
| Collana | Drugs and Alcohol Today |
| Soggetto topico | Drugs - Law and legislation |
| ISBN | 1-80117-965-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover -- Relevance of cryptomarkets, characteristics of purchasers and possibilities for survey research: experience from the European Web Survey on Drugs -- Psychedelic substance use in the Reddit psychonaut community. A qualitative study on motives and modalities -- Drugs, brands and consumer culture: the sign-value of the products sold on the darknet marketplaces -- Pricing of illicit drugs on darknet markets: a conceptual exploration -- Concentration of tetrahidrocannabinol in joints -- When policy fails try something different integrated practice improve outcomes for dual diagnosis co-occurring service users accessing mental health services -- Outline placeholder -- Drugs, technologies and cyber markets: an introduction -- References. |
| Record Nr. | UNINA-9910794534203321 |
Sultan Aysel
|
||
| [Place of publication not identified] : , : Emerald Publishing, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs, technologies and cyber markets / / guest editors, Karenza Moore and Angus Bancroft
| Drugs, technologies and cyber markets / / guest editors, Karenza Moore and Angus Bancroft |
| Autore | Sultan Aysel |
| Pubbl/distr/stampa | [Place of publication not identified] : , : Emerald Publishing, , [2021] |
| Descrizione fisica | 1 online resource (77 pages) |
| Disciplina | 344.04233 |
| Collana | Drugs and Alcohol Today |
| Soggetto topico | Drugs - Law and legislation |
| ISBN | 1-80117-965-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover -- Relevance of cryptomarkets, characteristics of purchasers and possibilities for survey research: experience from the European Web Survey on Drugs -- Psychedelic substance use in the Reddit psychonaut community. A qualitative study on motives and modalities -- Drugs, brands and consumer culture: the sign-value of the products sold on the darknet marketplaces -- Pricing of illicit drugs on darknet markets: a conceptual exploration -- Concentration of tetrahidrocannabinol in joints -- When policy fails try something different integrated practice improve outcomes for dual diagnosis co-occurring service users accessing mental health services -- Outline placeholder -- Drugs, technologies and cyber markets: an introduction -- References. |
| Record Nr. | UNINA-9910813191803321 |
|
Sultan Aysel
|
||
| [Place of publication not identified] : , : Emerald Publishing, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dual Markets : Comparative Approaches to Regulation / / edited by Ernesto U. Savona, Mark A.R. Kleiman, Francesco Calderoni
| Dual Markets : Comparative Approaches to Regulation / / edited by Ernesto U. Savona, Mark A.R. Kleiman, Francesco Calderoni |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XVIII, 402 p. 12 illus., 10 illus. in color.) |
| Disciplina | 344.04233 |
| Soggetto topico |
Criminology
Conflict of laws Health promotion Criminology and Criminal Justice, general Private International Law, International & Foreign Law, Comparative Law Health Promotion and Disease Prevention |
| ISBN | 3-319-65361-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910255263403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Food and drug regulation in an era of globalized markets / / edited by Sam F. Halabi
| Food and drug regulation in an era of globalized markets / / edited by Sam F. Halabi |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (258 p.) |
| Disciplina | 344.04233 |
| Soggetto topico |
Drugs - Law and legislation
Pharmacy - Law and legislation Food law and legislation |
| ISBN | 0-12-802550-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Food and Drug Regulation in an Era of Globalized Markets; Copyright; Contents; Contributors; Foreword; Introduction; The Rise of a Global System for Food and Pharmaceuticals; Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance; The Plan of This Book; Acknowledgments; Acknowledgments; Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains ; Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem; Introduction
Approaches to Reduce Drug Development Costs and Speed Innovation Clinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings; Adaptive Design; Clinical Trials: Globalization; New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring; The Supply Chain: How Are We Vulnerable and What Are Potential Solutions?; Big (More and More) Data: Swim or Drown?; Conclusion; Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities; Introduction; Adulteration, Misbranding, and GMPs FDA Establishment Inspections FDA Enforcement Instruments Related to Manufacturing; Foreign Inspections; Conclusion; Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union; Introduction; Approval of Drugs in Europe; The European Medicines Agency: Its Role and Activities; Ema Support In The Early Stages Of Drug Development; The Centralized Procedure AT WORK; Assessment overview; Single Assessment Report; Patients in the Scientific Review Process; Transparency and the Centralized Procedure; EMA-FDA Cooperation; Cooperation in the Product Life Cycle Cooperation in Inspections Benefits of International Cooperation; References; Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues; Introduction; Taking Clinical Trials Abroad; Overlapping Legal and Regulatory Requirements; Legal Landscape in the United States: FDA Oversight of Clinical Trials; Legal Landscape in the EU: EU Clinical Trial Directives and Regulation; International Legal Landscape: International Clinical Practice Standards; National and Local Legal Standards; Practical Considerations in Conducting Global Trials Deciding Whether to Conduct the Foreign Clinical Trial Under an IND Identifying Experienced Contractors and Contract Research Organizations; Managing Idiosyncratic Foreign Sites and Investigators; Conclusion; Further Reading; Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions; Globalization's Influence on the Pharmaceutical Supply Chain; The Effects of the Global Market for Falsified and Substandard Medicines; Barriers to Global Solutions for the Problem of Falsified and Substandard Medicines Combating Falsified and Substandard Medicines through Regulatory Cooperation |
| Record Nr. | UNINA-9910797549503321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Food and drug regulation in an era of globalized markets / / edited by Sam F. Halabi
| Food and drug regulation in an era of globalized markets / / edited by Sam F. Halabi |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (258 p.) |
| Disciplina | 344.04233 |
| Soggetto topico |
Drugs - Law and legislation
Pharmacy - Law and legislation Food law and legislation |
| ISBN | 0-12-802550-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Food and Drug Regulation in an Era of Globalized Markets; Copyright; Contents; Contributors; Foreword; Introduction; The Rise of a Global System for Food and Pharmaceuticals; Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance; The Plan of This Book; Acknowledgments; Acknowledgments; Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains ; Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem; Introduction
Approaches to Reduce Drug Development Costs and Speed Innovation Clinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings; Adaptive Design; Clinical Trials: Globalization; New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring; The Supply Chain: How Are We Vulnerable and What Are Potential Solutions?; Big (More and More) Data: Swim or Drown?; Conclusion; Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities; Introduction; Adulteration, Misbranding, and GMPs FDA Establishment Inspections FDA Enforcement Instruments Related to Manufacturing; Foreign Inspections; Conclusion; Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union; Introduction; Approval of Drugs in Europe; The European Medicines Agency: Its Role and Activities; Ema Support In The Early Stages Of Drug Development; The Centralized Procedure AT WORK; Assessment overview; Single Assessment Report; Patients in the Scientific Review Process; Transparency and the Centralized Procedure; EMA-FDA Cooperation; Cooperation in the Product Life Cycle Cooperation in Inspections Benefits of International Cooperation; References; Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues; Introduction; Taking Clinical Trials Abroad; Overlapping Legal and Regulatory Requirements; Legal Landscape in the United States: FDA Oversight of Clinical Trials; Legal Landscape in the EU: EU Clinical Trial Directives and Regulation; International Legal Landscape: International Clinical Practice Standards; National and Local Legal Standards; Practical Considerations in Conducting Global Trials Deciding Whether to Conduct the Foreign Clinical Trial Under an IND Identifying Experienced Contractors and Contract Research Organizations; Managing Idiosyncratic Foreign Sites and Investigators; Conclusion; Further Reading; Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions; Globalization's Influence on the Pharmaceutical Supply Chain; The Effects of the Global Market for Falsified and Substandard Medicines; Barriers to Global Solutions for the Problem of Falsified and Substandard Medicines Combating Falsified and Substandard Medicines through Regulatory Cooperation |
| Record Nr. | UNINA-9910818197303321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Legislazione farmaceutica / Paola Minghetti, Marcello Marchetti
| Legislazione farmaceutica / Paola Minghetti, Marcello Marchetti |
| Autore | Minghetti, Paola |
| Edizione | [7. ed] |
| Pubbl/distr/stampa | Milano : CEA, 2013 |
| Descrizione fisica | XVIII, 766 p. ; 24 cm. |
| Disciplina | 344.04233 |
| Altri autori (Persone) | Marchetti, Marcello |
| Soggetto topico | Farmaci - Legislazione |
| ISBN | 978-88-08-18402-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ita |
| Record Nr. | UNIBAS-000034392 |
|
Minghetti, Paola
|
||
| Milano : CEA, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. della Basilicata | ||
| ||
Legislazione farmaceutica / Paola Minghetti, Marcello Marchetti
| Legislazione farmaceutica / Paola Minghetti, Marcello Marchetti |
| Autore | Minghetti, Paola |
| Edizione | [6. ed] |
| Pubbl/distr/stampa | Milano : CEA, 2010 |
| Descrizione fisica | XVIII, 749 p. ; 24 cm. |
| Disciplina | 344.04233 |
| Altri autori (Persone) | Marchetti, Marcello |
| Soggetto topico | Farmaci - Legislazione |
| ISBN | 978-88-08-18478-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ita |
| Record Nr. | UNIBAS-000030720 |
|
Minghetti, Paola
|
||
| Milano : CEA, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. della Basilicata | ||
| ||
